Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass

著者: Bart Keymeulen, Melanie Walter, Chantal Mathieu, L. Kaufman, Frans Gorus, Robert Hilbrands, Evy Vandemeulebroucke, Ursule Van de Velde, Laurent Crenier, Christophe De Block, Sophie Candon, Herman Waldmann, A G Ziegler, Lucienne Chatenoud, Daniël Pipeleers - Diabetologia 2010 被引用: 313